Literature DB >> 3800458

A reappraisal of oophorectomy in carcinoma of the breast.

U Veronesi, N Cascinelli, M Greco, G Di Fronzo, R Oriana, M Merson, D Galluzzo, R Bufalino, F Belli, V Sacchini.   

Abstract

Bilateral oophorectomy was used to treat 601 patients with disseminated breast carcinoma from 1974-1984. The total response rate was 31.2%. Complete regression occurred in 10.5% of patients and partial regression occurred in 20.8%, whereas 28.3% of patients showed no change and the disease progressed in 36.9% of patients. The patients who had a total regression had good survival rates (60.8% at 5 years and 47.3% at 7 years). No significant differences were found in the various age groups or with different types of dissemination. Patients with syncronous primary carcinoma and distant metastases had a high rate of regression as did patients with slow-growing carcinomas that metastasized many years after primary treatment. Estrogen receptor (ER) rates were good indicators of response only when determined on metastatic tissue at the time of oophorectomy. The value of ER determined on the primary tumor was of limited predictivity of response. A total of 220 patients received chemotherapy before oophorectomy. In this group the response rate was 22.3%, lower than that observed in patients who did not receive chemotherapy (36.6%). No important differences in total response rates were found among patients with amenorrhea and without amenorrhea although total regressions were more frequent in the latter patients than in the former patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800458      PMCID: PMC1492886          DOI: 10.1097/00000658-198701000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Oophorectomy for advanced carcinoma of the breast.

Authors:  U Veronesi; G Pizzocaro; A Rossi
Journal:  Surg Gynecol Obstet       Date:  1975-10

2.  The role of prophylactic castration in the therapy of human mammary cancer.

Authors:  R Nissen-Meyer
Journal:  Eur J Cancer       Date:  1967-11       Impact factor: 9.162

3.  [The contraceptive pill and vascular accidents].

Authors:  M Lancet
Journal:  Harefuah       Date:  1983-02-01

4.  A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.

Authors:  S E Jones; J R Durant; F A Greco; A Robertone
Journal:  Cancer Treat Rev       Date:  1982-12       Impact factor: 12.111

5.  Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma.

Authors:  R G Ravdin; E F Lewison; N H Slack; T L Dao; B Gardner; D State; B Fisher
Journal:  Surg Gynecol Obstet       Date:  1970-12

6.  [Ovariectomy in the therapy of advanced carcinoma of the breast].

Authors:  U Veronesi; G Pizzocaro
Journal:  Tumori       Date:  1966 Nov-Dec
  6 in total
  1 in total

1.  Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.

Authors:  Kanami Uchiumi; Kouki Tsuboi; Nozomi Sato; Takako Ito; Hisashi Hirakawa; Toshifumi Niwa; Yuri Yamaguchi; Shin-Ichi Hayashi
Journal:  Breast Cancer       Date:  2019-01-04       Impact factor: 4.239

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.